SIRT1 and neurodegenerative disease: NeuroHeal, an AI-designed compound to target neurodegenerative diseases, has been shown to activate both the SIRT1 and the PI3K/Akt signaling pathways, which converge on FOXO3 deacetylation and phosphorylation.